| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Dec'18 | ||
|---|---|---|---|---|---|---|
Assets | ||||||
Current assets: | ||||||
Cash | ||||||
109,637 | 92,117 | 95,954 | 108,536 | 63,380 | ||
Accounts receivable | ||||||
1,002 | 201 | 46 | 160 | 5,021 | ||
Prepaid expenses and other current assets | ||||||
4,248 | 4,884 | 3,536 | 2,021 | 2,076 | ||
Research and development incentives receivable | ||||||
8,503 | 6,944 | 10,714 | 9,735 | 6,292 | ||
Total current assets | ||||||
123,390 | 104,146 | 110,250 | 120,452 | 76,769 | ||
Property and equipment, net | ||||||
2,203 | 2,292 | 2,152 | 2,002 | 1,818 | ||
Operating lease right-of-use assets | ||||||
1,815 | 2,056 | 2,177 | 2,386 | - | ||
Other assets | ||||||
1,874 | 1,700 | 1,481 | 1,406 | 3,039 | ||
Total assets | ||||||
129,282 | 110,194 | 116,060 | 126,246 | 81,626 | ||
Liabilities and shareholders’ equity | ||||||
Current liabilities: | ||||||
Accounts payable | ||||||
4,434 | 1,949 | 1,992 | 2,569 | 1,887 | ||
Accrued expenses and other current liabilities | ||||||
5,716 | 6,144 | 6,035 | 5,859 | 7,032 | ||
Deferred revenue, current portion | ||||||
6,047 | 728 | 808 | 1,012 | 10 | ||
Total current liabilities | ||||||
16,197 | 8,821 | 8,835 | 9,440 | 8,929 | ||
Warrant liability | ||||||
- | - | - | - | 4,804 | ||
Operating lease liabilities | ||||||
1,056 | 1,251 | 1,416 | 1,628 | - | ||
Deferred revenue, net of current portion | ||||||
28,206 | 4,929 | 9,055 | 9,358 | 14,625 | ||
Other long-term liabilities | ||||||
2,010 | 1,995 | 1,429 | 1,261 | 897 | ||
Total liabilities | ||||||
47,469 | 16,996 | 20,735 | 21,687 | 29,255 | ||
Shareholders’ equity: | ||||||
Ordinary shares, £0.01 nominal value; 31,995,653 shares authorized at March 31, 2020 and December 31, 2019; 18,016,207 and 17,993,701 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively | ||||||
227 | 227 | 226 | 226 | 10 | ||
Additional paid‑in capital | ||||||
197,179 | 195,056 | 193,850 | 193,178 | 1,857 | ||
Accumulated other comprehensive loss | ||||||
-3,719 | -1,535 | -2,607 | -2,183 | -1,751 | ||
Accumulated deficit | ||||||
-111,874 | -100,550 | -96,144 | -86,662 | -69,942 | ||
Total shareholders’ equity | ||||||
81,813 | 93,198 | 95,325 | 104,559 | -69,826 | ||
Total liabilities and shareholders’ equity | ||||||
129,282 | 110,194 | 116,060 | 126,246 | 81,626 | ||
Series A Convertible Preferred Shares | ||||||
Convertible preferred shares | ||||||
- | - | - | - | 41,820 | ||
Series B1 Convertible Preferred Shares | ||||||
Convertible preferred shares | ||||||
- | - | - | - | 54,621 | ||
Series B2 Convertible Preferred Shares | ||||||
Convertible preferred shares | ||||||
- | - | - | - | 25,756 | ||